Výsledky vyhledávání - "фармакотерапия"
-
1
Zdroj: Ukrainian Neurosurgical Journal; Vol. 31 No. 1 (2025); 3-11
Ukrainian Neurosurgical Journal; Том 31 № 1 (2025); 3-11Témata: фантомний біль, персоналізований підхід, методи лікування, персонализированный подход, методы лечения, personalized approach, интервенционное лечение, pharmacotherapy, phantom limb pain, interventional treatment, фантомная боль, фармакотерапія, фармакотерапия, інтервенційне лікування, treatment methods
Popis souboru: application/pdf; text/html
Přístupová URL adresa: https://theunj.org/article/view/318305
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Autoři: a další
Zdroj: Pediatric pharmacology; Том 21, № 6 (2024); 539-550 ; Педиатрическая фармакология; Том 21, № 6 (2024); 539-550 ; 2500-3089 ; 1727-5776
Témata: фармакогеномика, pharmacotherapy, gut microbiota, gut–brain axis, pharmacogenomics, фармакотерапия, микробиота кишечника, ось «мозг – кишечник»
Popis souboru: application/pdf
Relation: https://www.pedpharma.ru/jour/article/view/2557/1658; Alyasi AS, Altawili MA, Alabbadi AF, et al. Pharmacological Management for Pediatric Irritable Bowel Syndrome: A Review. Cureus. 2023;15(11):e49197. https://doi.org/10.7759/cureus.49197; Halland M, Saito YA. Irritable bowel syndrome: new and emerging treatments. BMJ. 2015;350:h1622. https://doi.org/10.1136/bmj.h1622; Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017;6(11):99. https://doi.org/10.3390/jcm6110099; Hyams JS, Di Lorenzo C, Saps M, et al. Functional Disorders: Children and Adolescents. Gastroenterology. 2016:S00165085(16)00181-5. https://doi.org/10.1053/j.gastro.2016.02.015; Soares RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol. 2014;20(34):12144–12160. https://doi.org/10.3748/wjg.v20.i34.12144; Yu SJ, Lee HS, Gung HJ, et al. IBS Research Study Group of the Korean Society of Neurogastroenterology and Motility. Efficacy of a Restrictive Diet in Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis. Korean J Gastroenterol. 2022;80(1):6– 16. https://doi.org/10.4166/kjg.2022.014; Ng QX, Soh AYS, Loke W, et al. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018;11:345–349. https://doi.org/10.2147/JIR.S174982; Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57(1):1–24. https://doi.org/10.1007/s00394-0171445-8; Gill PA, Inniss S, Kumagai T, et al. The Role of Diet and Gut Microbiota in Regulating Gastrointestinal and Inflammatory Disease. Front Immunol. 2022;13:866059. https://doi.org/10.3389/fimmu.2022.866059; Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One. 2015;10(5):e0126982. https://doi.org/10.1371/journal.pone.0126982; Rughwani T. Current Awareness and Tools Available for StressInduced IBS in Children. 2024. In: Digital Commons @ Garrisburg University: Website. Available online: https://digitalcommons.harrisburgu.edu/dandt/13. Accessed on August 31, 2024.; Chogle A, Mintjens S, Saps M. Pediatric IBS: an overview on pathophysiology, diagnosis and treatment. Pediatr Ann. 2014;43(4):e76–e82. https://doi.org/10.3928/0090448120140325-08; Algera J, Lövdahl J, Sjölund J, et al. Managing pain in irritable bowel syndrome: current perspectives and best practice. Expert Rev Gastroenterol Hepatol. 2023;17(9):871–881. https://doi.org/10.1080/17474124.2023.2242775; Jing F, Zhang J. Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders. Dig Dis Sci. 2014;59(11):2642–2648. https://doi.org/10.1007/s10620-014-3244-x; Chen M, Ruan G, Chen L, et al. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Front Endocrinol (Lausanne). 2022;13:817100. https://doi.org/10.3389/fendo.2022.817100; Fu R, Chen M, Chen Y, et al. Expression and clinical significance of 5-HT and 5-HT3R in the intestinal mucosa of patient with diarrhea-type irritable bowel syndrome. Exp Ther Med. 2019;17(4):3077–3082. https://doi.org/10.3892/etm.2019.7297; Stasi C, Bellini M, Gambaccini D, et al. Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study. J Neurogastroenterol Motil. 2017;23(3):428–434. https://doi.org/10.5056/jnm16155; Kridler J, Kamat D. Irritable Bowel Syndrome: A Review for General Pediatricians. Pediatr Ann. 2016;45(1):e30–e33. https://doi.org/10.3928/00904481-20151208-01; Ford AC, Bercik P, Morgan DG, et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013;145(6):1262–1270.e1. https://doi.org/10.1053/j.gastro.2013.08.048; Palsson OS, Whitehead WE, van Tilburg MA, et al. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Gastroenterology. 2016:S0016-5085(16)00180-3. https://doi.org/10.1053/j.gastro.2016.02.014; Singh SV, Ganguly R, Jaiswal K, et al. Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: A comprehensive review. World J Clin Cases. 2023;11(19):4458–4476. https://doi.org/10.12998/wjcc.v11.i19.4458; Appleton J. The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integr Med (Encinitas). 2018;17(4):28–32.; Mayer EA, Ryu HJ, Bhatt RR. The neurobiology of irritable bowel syndrome. Mol Psychiatry. 2023;28(4):1451–1465. https://doi.org/10.1038/s41380-023-01972-w; Cerdó T, García-Santos JA, Rodríguez-Pöhnlein A, et al. Impact of Total Parenteral Nutrition on Gut Microbiota in Pediatric Population Suffering Intestinal Disorders. Nutrients. 2022;14(21):4691. https://doi.org/10.3390/nu14214691; Craven LJ, Silverman M, Burton JP. Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening criteria. Ann Transl Med. 2017;5(24):490. https://doi.org/10.21037/atm.2017.10.03; De Palma G, Lynch MD, Lu J, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9(379):eaaf6397. https://doi.org/10.1126/scitranslmed.aaf6397; Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World J Gastroenterol. 2018;24(21):2211–2235. https://doi.org/10.3748/wjg.v24.i21.2211; Donnet AS, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol. 2022;15:17562848221074208. https://doi.org/10.1177/17562848221074208; Rexwinkel R, de Bruijn CMA, Gordon M, et al. Pharmacologic Treatment in Functional Abdominal Pain Disorders in Children: A Systematic Review. Pediatrics. 2021;147(6):e2020042101. https://doi.org/10.1542/peds.2020-042101; Dwyer JB, Bloch MH. Antidepressants for Pediatric Patients. Curr Psychiatr. 2019;18(9):26–42F.; Bonilla S, Nurko S. Focus on the use of antidepressants to treat pediatric functional abdominal pain: current perspectives. Clin Exp Gastroenterol. 2018;11:365–372. https://doi.org/10.2147/CEG.S146646; Deodhar M, Rihani SBA, Darakjian L, et al. Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition. Pharmaceutics. 2021;13(2):148. https://doi.org/10.3390/pharmaceutics13020148; Huang X, Li C, Li C, et al. CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population. Front Pharmacol. 2021;12:730461. https://doi.org/10.3389/fphar.2021.730461; Maciaszek J, Pawłowski T, Hadryś T, et al. The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression. Int J Mol Sci. 2023;24(17):13459. https://doi.org/10.3390/ijms241713459; Ford AC, Wright-Hughes A, Alderson SL, et al. ATLANTIS trialists. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;402(10414):1773–1785. https://doi.org/10.1016/S0140-6736(23)01523-4; Nassan M, Nicholson WT, Elliott MA, et al. Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine. Mayo Clin Proc. 2016;91(7):897–907. https://doi.org/10.1016/j.mayocp.2016.02.023; Dean L. Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. In: Medical Genetics Summaries. Pratt VM, Scott SA, Pirmohamed M, et al., eds. Bethesda (MD): National Center for Biotechnology Information (US); 2017.; Radosavljevic M, Svob Strac D, Jancic J, Samardzic J. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy. Genes (Basel). 2023;14(5):1095. https://doi.org/10.3390/genes14051095; Pirmohamed M. Pharmacogenomics: current status and future perspectives. Nat Rev Genet. 2023;24(6):350–362. https://doi.org/10.1038/s41576-022-00572-8; Thümmler S, Dor E, David R, et al. Pharmacoresistant Severe Mental Health Disorders in Children and Adolescents: Functional Abnormalities of Cytochrome P450 2D6. Front Psychiatry. 2018;9:2. https://doi.org/10.3389/fpsyt.2018.00002; Austin-Zimmerman I, Wronska M, Wang B, et al. The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics. Genes (Basel). 2021;12(11):1758. https://doi.org/10.3390/genes12111758; Lam D, Ancelin ML, Ritchie K, et al. Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression. BMC Psychiatry. 2018;18(1):282. https://doi.org/10.1186/s12888-018-1850-4; Taylor MJ, Sen S, Bhagwagar Z. Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol Psychiatry. 2010;68(6):536–543. https://doi.org/10.1016/j.biopsych.2010.04.034; Jukic M, Milosavljević F, Molden E, Ingelman-Sundberg M. Pharmacogenomics in treatment of depression and psychosis: an update. Trends Pharmacol Sci. 2022;43(12):1055–1069. https://doi.org/10.1016/j.tips.2022.09.011; Aka I, Bernal CJ, Carroll R, et al. Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children. J Pers Med. 2017;7(4):14. https://doi.org/10.3390/jpm7040014; Lu PL, Velasco-Benítez CA, Saps M. Sex, Age, and Prevalence of Pediatric Irritable Bowel Syndrome and Constipation in Colombia: A Population-based Study. J Pediatr Gastroenterol Nutr. 2017;64(6):e137–e141. https://doi.org/10.1097/MPG.0000000000001391; Karunanayake A, Devanarayana NM, Rajindrajith S. Early life events in functional abdominal pain disorders in children. PLoS One. 2022;17(11):e0275419. https://doi.org/10.1371/journal.pone.0275419; Koppen IJ, Nurko S, Saps M, et al. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol. 2017;11(3):193–201. https://doi.org/10.1080/17474124.2017.1282820; Trinkley KE, Nahata MC. Medication management of irritable bowel syndrome. Digestion. 2014;89(4):253–267. https://doi.org/10.1159/000362405; Roohafza H, Pourmoghaddas Z, Saneian H, Gholamrezaei A. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial. Neurogastroenterol Motil. 2014;26(11):1642–1650. https://doi.org/10.1111/nmo.12444; Seetharaman J, Poddar U, Yachha SK, et al. Efficacy of amitriptyline in pediatric functional abdominal pain disorders: A randomized placebo-controlled trial. J Gastroenterol Hepatol. 2022;37(4):685–691. https://doi.org/10.1111/jgh.15765; Saps M, Youssef N, Miranda A, et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137(4):1261–1269. https://doi.org/10.1053/j.gastro.2009.06.060; Crawford J, Tran P, Shaw JS, Shaw RJ. Current Pharmacological Treatments for Childhood-Onset Somatic Symptom and Related Disorders (SSRD) and Functional Gastrointestinal Disorders (FGID). Current Treatment Options in Psychiatry. 2020;7:120–143. https://doi.org/10.1007/s40501-020-00209-9; Guandalini S, Magazzù G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51(1):24–30. https://doi.org/10.1097/MPG.0b013e3181ca4d95; Sudha MR, Jayanthi N, Aasin M, et al. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Benef Microbes. 2018;9(4):563–572. https://doi.org/10.3920/BM2017.0129; Francavilla R, Miniello V, Magistà AM, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010;126(6):e1445–e1452. https://doi.org/10.1542/peds.2010-0467; Menon J, Thapa BR, Kumari R, et al. Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial. J Pediatr Gastroenterol Nutr. 2023;76(1):14–19. https://doi.org/10.1097/MPG.0000000000003622; Shulman RJ, Hollister EB, Cain K, et al. Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial. Clin Gastroenterol Hepatol. 2017;15(5):712–719.e4. https://doi.org/10.1016/j.cgh.2016.03.045; Ogawa N, Nakajima S, Tamada K, et al. Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages. Arch Biochem Biophys. 2021;711:109029. https://doi.org/10.1016/j.abb.2021.109029; Karabulut GS, Beşer OF, Erginöz E, et al. The Incidence of Irritable Bowel Syndrome in Children Using the Rome III Criteria and the Effect of Trimebutine Treatment. J Neurogastroenterol Motil. 2013;19(1):90–93. https://doi.org/10.5056/jnm.2013.19.1.90; Kaneto H, Takahashi M, Watanabe J. The opioid receptor selectivity for trimebutine in isolated tissues experiments and receptor binding studies. J Pharmacobiodyn. 1990;13(7):448–453. https://doi.org/10.1248/bpb1978.13.448; https://www.pedpharma.ru/jour/article/view/2557
-
11
Autoři: a další
Zdroj: Neurology, Neuropsychiatry, Psychosomatics; Vol 17, No 2 (2025); 55-62 ; Неврология, нейропсихиатрия, психосоматика; Vol 17, No 2 (2025); 55-62 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2025-2
Témata: нестероидные противовоспалительные препараты, sciatica, tension-type headache, insomnia, neck pain, musculoskeletal pain, chronic factors, treatment, kinesiotherapy, medical gymnastics, pharmacotherapy, nimesulide, non-steroidal anti-inflammatory drugs, люмбоишиалгия, головная боль напряжения, инсомния, боль в шее, скелетно-мышечная боль, факторы хронизации, лечение, кинезиотерапия, лечебная гимнастика, фармакотерапия, нимесулид
Popis souboru: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/2483/1792; Bikbov MM, Kazakbaeva GM, Zainullin RM, et al. Prevalence of and factors associated with low Back pain, thoracic spine pain and neck pain in Bashkortostan, Russia: the Ural Eye and Medical Study. BMC Musculoskelet Disord. 2020 Feb 1;21(1):64. doi:10.1186/s12891-020-3080-4; GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-858. doi:10.1016/S0140-6736(18)32279-7; Парфенов ВА, Яхно НН, Давыдов ОС и др. Хроническая неспецифическая (скелетно-мышечная) поясничная боль. Рекомендации Российского общества по изучению боли (РОИБ). Неврология, нейропсихиатрия, психосоматика. 2019;11(2S):7-16. doi:10.14412/2074-2711-2019-2S-7-16; Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: systematic review. Rev Saude Publica. 2015;49:1. doi:10.1590/S0034-8910.2015049005874. Epub 2015 Oct 20.; Ashina S, Lipton RB, Bendtsen L, et al. Increased pain sensitivity in migraine and tension-type headache coexistent with low back pain: A cross-sectional population study. Eur J Pain. 2018;22(5):904-14. doi:10.1002/ejp.1176. Epub 2018 Jan 19.; Yoon MS, Manack A, Schramm S, et al. Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: results of the German Headache Consortium study. Pain. 2013 Mar;154(3):484-92. doi:10.1016/j.pain.2012.12.010. Epub 2012 Dec 28.; Miranda H, Viikari-Juntura E, Punnett L, Riihimäki H. Occupational loading, health behavior and sleep disturbance as predictors of low-back pain. Scand J Work Environ Health. 2008 Dec;34(6):411-9. doi:10.5271/sjweh.1290; Осипова ВВ. Диагностика и лечение головной боли напряжения в амбулаторной практике врача-терапевта. Consilium Medicum. 2020;22(9):57-64. doi:10.26442/20751753.2020.9.200175; Hong JH, Kim HD, Shin HH, Huh B. Assessment of depression, anxiety, sleep disturbance, and quality of life in patients with chronic low back pain in Korea. Korean J Anesthesiol. 2014 Jun;66(6):444-50. doi:10.4097/kjae.2014.66.6.444. Epub 2014 Jun 26.; Song TJ, Cho SJ, Kim WJ, et al. Anxiety and Depression in Tension-Type Headache: A Population-Based Study. PLoS One. 2016 Oct 26;11(10):e0165316. doi:10.1371/journal.pone.0165316; Полуэктов МГ, Шувахина НА, Ламкова ИА. Взаимоотношения боли и сна в клинической практике. РМЖ. 2019;(9):56-60. Доступно по ссылке: https://www.rusmedreview.com/upload/iblock/da9/56-60.pdf; Hodges PW, Danneels L. Changes in Structure and Function of the Back Muscles in Low Back Pain: Different Time Points, Observations, and Mechanisms. J Orthop Sports Phys Ther. 2019 Jun;49(6):464-76. doi:10.2519/jospt.2019.8827; Полуэктов МГ, Бузунов РВ, Авербух ВМ и др. Проект клинических рекомендаций по диагностике и лечению хронической инсомнии у взрослых. Consilium Medicum. Неврология и Ревматология (Прил.). 2016;(2):41-51. Доступно по ссылке: https://rossleep.ru/wpcontent/uploads/2016/11/KLINICHESKIEREKOMENDATSII-PO-INSOMNIIv.1.2.pdf.; Bendtsen L, Evers S, Linde M, et al; EFNS. EFNS guideline on the treatment of tensiontype headache – report of an EFNS task force. Eur J Neurol. 2010 Nov;17(11):1318-25. doi:10.1111/j.1468-1331.2010.03070.x; Парфенов ВА, Яхно НН, Кукушкин МЛ и др. Неспецифическая боль в шее (цервикалгия). Рекомендации Российского общества по изучению боли (РОИБ). Неврология, нейропсихиатрия, психосоматика. 2023;15(5):4-12. doi:10.14412/2074-27112023-5-4-12; Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi:10.1177/0333102417738202; Головачева ВА, Головачева АА. Эффективный комплексный подход к ведению пациентов с хронической скелетно-мышечной болью в нижней части спины и болями других локализаций. Медицинский Совет. 2024;(3):108-16. doi:10.21518/ms2024-139; Головачева ВА, Головачева АА, Таршилова АР. Хроническая скелетно-мышечная боль в спине: ошибки при ведении пациентов и вопросы оптимизации. Неврология, нейропсихиатрия, психосоматика. 2024;16(3):103-9. doi:10.14412/2074-2711-2024-3-103-109; Головачева ВА, Головачева АА. Успешные комбинации лекарственной и нелекарственной терапии при болях в нижней части спины. Российский журнал боли. 2024;22(1):57-67. doi:10.17116/pain20242201157; Головачева АА, Головачева ВА. Кинезиотерапия при хронической боли в спине и сочетанной головной боли напряжения. Российский неврологический журнал. 2023;28(3):61-8. doi:10.30629/2658-7947-2023-28-3-61-68; Головачева ВА, Табеева ГР, Головачева АА. Неспецифическая боль в нижней части спины: принципы и алгоритмы успешного ведения пациентов в реальной клинической практике. Неврология, нейропсихиатрия, психосоматика. 2023;15(3):85-94. doi:10.14412/2074-2711-2023-3-85-94; Головачева АА, Головачева ВА. Типичная тактика ведения пациентов с хронической неспецифической болью в спине и головной болью напряжения. Неврология, нейропсихиатрия, психосоматика. 2024;16(5):9-16. doi:10.14412/2074-2711-2024-5-9-16; Головачева АА, Головачева ВА. Комплексное лечение пациентов с хронической неспецифической болью в спине и коморбидными нарушениями: проспективное клиническое исследование. Неврология, нейропсихиатрия, психосоматика. 2024;16(6):45-52. doi:10.14412/2074-2711-2024-6-45-52; Головачева АА, Головачева ВА, Фатеева ТГ. Эффективность кинезиотерапии при головной боли напряжения и хронической неспецифической боли в спине: проспективное рандомизированное исследование. Медицинский Совет. 2024;(22):72-9. doi:10.21518/ms2024-525; Hayden JA, Ellis J, Ogilvie R, et al. Some types of exercise are more effective than others in people with chronic low back pain: a network meta-analysis. J Physiother. 2021 Oct;67(4):252-62. doi:10.1016/j.jphys.2021.09.004. Epub 2021 Sep 16.; Amaral S, Passaro AC, Casarotto RA. Effect of the association of continuous shortwave diathermy and Pilates-based exercises on pain, depression, and anxiety in chronic non-specific low back pain: a randomized clinical trial. Braz J Med Biol Res. 2023 Mar 17;56:e12338. doi:10.1590/1414-431X2023e12338; Wood L, Bejarano G, Csiernik B, et al. Pain catastrophising and kinesiophobia mediate pain and physical function improvements with Pilates exercise in chronic low back pain: a mediation analysis of a randomised controlled trial. J Physiother. 2023 Jul;69(3):168-74. doi:10.1016/j.jphys.2023.05.008. Epub 2023 Jun 3.; Leite A, Matignon A, Marlot L, et al. The Impact of Clinical Pilates Exercises on Tension-Type Headaches: A Case Series. Behav Sci (Basel). 2023 Jan 27;13(2):105. doi:10.3390/bs13020105; Choi W. Effect of 4 Weeks of Cervical Deep Muscle Flexion Exercise on Headache and Sleep Disorder in Patients with Tension Headache and Forward Head Posture. Int J Environ Res Public Health. 2021 Mar 25;18(7):3410. doi:10.3390/ijerph18073410; Oliveira CB, Maher CG, Pinto RZ, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018 Nov;27(11):2791-803. doi:10.1007/s00586-018-5673-2. Epub 2018 Jul 3.; Котова ОВ, Акарачкова ЕС. Нимесулид: эффективность и безопасность применения. Consilium Medicum. 2016;18(2):100-3. Доступно по ссылке: https://cyberleninka.ru/article/n/nimesulid-effektivnost-i-bezopasnostprimeneniya; Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7563-8. doi:10.1073/pnas.96.13.7563. Erratum in: Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9666.; Shah AA, Thjodleifsson B, Murray FE, et al. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut. 2001 Mar;48(3):339-46. doi:10.1136/gut.48.3.339; Rostom A, Muir K, Dube C, et al. Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf. 2009;1:47-71. doi:10.2147/dhps.s4334. Epub 2009 Oct 28.; Conforti A, Leone R, Moretti U, et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Drug Saf. 2001;24(14):1081-90. doi:10.2165/00002018-200124140-00006
-
12
Autoři: a další
Zdroj: Neurology, Neuropsychiatry, Psychosomatics; Vol 17, No 2 (2025); 76-81 ; Неврология, нейропсихиатрия, психосоматика; Vol 17, No 2 (2025); 76-81 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2025-2
Témata: нестероидные противовоспалительные препараты, shoulder pain, cervicobrachialgia, musculoskeletal pain, chronic factors, treatment, kinesiotherapy, medical gymnastics, pharmacotherapy, dexketoprofen, Dexalgin, non-steroidal anti-inflammatory drugs, боль в плече, цервикобрахиалгия, скелетно-мышечная боль, факторы хронизации, лечение, кинезиотерапия, лечебная гимнастика, фармакотерапия, декскетопрофен, Дексалгин
Popis souboru: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/2488/1795; Popescu A, Lee H. Neck Pain and Lower Back Pain. Med Clin North Am. 2020 Mar;104(2):279-92. doi:10.1016/j.mcna.2019.11.003. Epub 2019 Dec 20.; Jahre H, Grotle M, Smedbraten K, et al. Risk factors for non-specific neck pain in youngadults. A systematic review. BMC Musculoskelet Disord. 2020 Jun 9;21(1):366. doi:10.1186/s12891-020-03379-y; Cho CY, Hwang YS, Cherng RJ. Musculoskeletal symptoms and associated risk factors among office workers with high workload computer use. J Manipulative Physiol Ther. 2012 Sep;35(7):534-40. doi:10.1016/j.jmpt.2012.07.004. Epub 2012 Aug 27.; Brandt M, Sundstrup E, Jakobsen MD, et al. Association between Neck/Shoulder Painand Trapezius Muscle Tenderness in Office Workers. Pain Res Treat. 2014;2014:352735. doi:10.1155/2014/352735. Epub 2014 Mar 27.; Парфенов ВА, Яхно НН, Кукушкин МЛ и др. Неспецифическая боль в шее (цервикалгия). Рекомендации Российского общества по изучению боли (РОИБ). Неврология, нейропсихиатрия, психосоматика. 2023;15(5):4-12. doi:10.14412/2074-27112023-5-4-12; Головачева ВА, Головачева АА. Хроническая боль в шее и сочетанная головная боль напряжения: единый эффективный подход к лечению. Неврология, нейропсихиатрия, психосоматика. 2024;16(4):76-84. doi:10.14412/2074-2711-2024-4-76-84; Головачева ВА, Головачева АА, Беляева СД. Цервикобрахиалгия и люмбоишиалгия: единый эффективный подход к решению проблемы. Медицинский Совет. 2024;(12):86-94. doi:10.21518/ms2024-309; Elbinoune I, Amine B, Shyen S, et al. Chronic neck pain and anxiety-depression: prevalence and associated risk factors. Pan Afr Med J. 2016 May 27;24:89. doi:10.11604/pamj.2016.24.89.8831; Corp N, Mansell G, Stynes S, et al. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2021 Feb;25(2):275-95. doi:10.1002/ejp.1679. Epub 2020 Nov 12.; Adam K, Gibson L, Cook M. Injury prevention in the meat industry: Limited evidence of effectiveness for ergonomic programs in reducing the severity of musculoskeletal injuries. Aust Occup Ther J. 2016 Feb;63(1):59-60. doi:10.1111/1440-1630.12276; Johnston V, Chen X, Welch A, et al. A cluster-randomized trial of workplace ergonomics and neck-specific exercise versus ergonomics and health promotion for office workers to manage neck pain – a secondary outcome analysis. BMC Musculoskelet Disord. 2021 Jan 12;22(1):68. doi:10.1186/s12891-021-03945-y; Shariat A, Cleland JA, Danaee M, et al. Effects of stretching exercise training and ergonomic modifications on musculoskeletal discomforts of office workers: a randomized controlled trial. Braz J Phys Ther. 2018 MarApr;22(2):144-53. doi:10.1016/j.bjpt.2017.09.003. Epub 2017 Sep 6.; Tunwattanapong P, Kongkasuwan R, Kuptniratsaikul V. The effectiveness of a neck and shoulder stretching exercise program among office workers with neck pain: a randomized controlled trial. Clin Rehabil. 2016 Jan;30(1):64-72. doi:10.1177/0269215515575747. Epub 2015 Mar 16.; Li Y, Li S, Jiang J, Yuan S. Effects of yoga on patients with chronic nonspecific neck pain: A PRISMA systematic review and meta-analysis. Medicine (Baltimore). 2019 Feb;98(8):e14649. doi:10.1097/MD.0000000000014649; Rasmussen-Barr E, Halvorsen M, Bohman T, et al. Summarizing the effects of different exercise types in chronic neck pain – a systematic review and meta-analysis of systematic reviews. BMC Musculoskelet Disord. 2023 Oct 12;24(1):806. doi:10.1186/s12891-023-06930-9; Akodu AK, Nwanne CA, Fapojuwo OA. Efficacy of neck stabilization and Pilates exercises on pain, sleep disturbance and kinesiophobia in patients with non-specific chronic neck pain: A randomized controlled trial. J Bodyw Mov Ther. 2021 Apr;26:411-9. doi:10.1016/j.jbmt.2020.09.008. Epub 2020 Oct 3.; Varol U, Valera-Calero JA, Sanchez-Jimenez E, et al. Levator Scapulae Stiffness Measurement Reliability in Individuals with and without Chronic Neck Pain by Experienced and Novel Examiners. Sensors (Basel). 2024 Jan 3;24(1):277. doi:10.3390/s24010277; Mueller J, Weinig J, Niederer D, et al. Resistance, Motor Control, and MindfulnessBased Exercises Are Effective for Treating Chronic Nonspecific Neck Pain: A Systematic Review With Meta-Analysis and DoseResponse Meta-Regression. J Orthop Sports Phys Ther. 2023;53(8):420-59. doi:10.2519/jospt.2023.11820; Park SH, Lee MM. Effects of Lower Trapezius Strengthening Exercises on Pain, Dysfunction, Posture Alignment, Muscle Thickness and Contraction Rate in Patients with Neck Pain; Randomized Controlled Trial. Med Sci Monit. 2020 Mar 23;26:e920208. doi:10.12659/MSM.920208; Tsiringakis G, Dimitriadis Z, Triantafylloy E, McLean S. Motor control training of deep neck flexors with pressure biofeedback improves pain and disability in patients with neck pain: A systematic review and meta-analysis. Musculoskelet Sci Pract. 2020 Dec;50:102220. doi:10.1016/j.msksp.2020.102220. Epub 2020 Jul 24.; Tsang SMH, So BCL, Lau RWL, et al. Comparing the effectiveness of integrating ergonomics and motor control to conventional treatment for pain and functional recovery of work-related neck-shoulder pain: A randomized trial. Eur J Pain. 2019 Jul;23(6):1141-52. doi:10.1002/ejp.1381. Epub 2019 Mar 11.; Khosrokiani Z, Letafatkar A, Gladin A. Lumbar motor control training as a complementary treatment for chronic neck pain: A randomized controlled trial. Clin Rehabil. 2022;36(1):99-112. doi:10.1177/02692155211038099; Toprak Celenay S, Mete O, Sari A, Ozer Kaya D. A comparison of kinesio taping and classical massage in addition to cervical stabilization exercise in patients with chronic neck pain. Complement Ther Clin Pract. 2021 May;43:101381. doi:10.1016/j.ctcp.2021.101381. Epub 2021 Apr 2.; Ay S, Konak HE, Evcik D, Kibar S. The effectiveness of Kinesio Taping on pain and disability in cervical myofascial pain syndrome. Rev Bras Reumatol Engl Ed. 2017 Mar-Apr;57(2):93-9. doi:10.1016/j.rbre.2016.03.012. Epub 2016 May 10.; Соловьева ЭЮ, Карнеев АН, Иваноков АН, Джутова ЭД. Декскетопрофен в лечении острой боли в спине. Эффективная фармакотерапия. Неврология и психиатрия. 2012;(5):36-40. Доступно по ссылке: https://umedp.ru/articles/deksketoprofen_v_lechenii_ostroy_boli_v_spine.html; Gaskell H, Derry S, Wiffen PJ, Moore RA. Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2017 May 25;5(5):CD007355. doi:10.1002/14651858.CD007355.pub3; Шавловская ОА. Оценка эффективности терапевтического действия препарата Дексалгин® (декскетопрофена трометамол) в лечении дорсопатии. Consilium Medicum. Неврология и ревматология (Прил.). 2012;(2):66-9. Доступно по ссылке: https://omnidoctor.ru/library/izdaniya-dlyavrachey/consilium-medicum/cm2012/nevro_2012_pril/nevro2012_2_pril/otsenkaeffektivnosti-terapevticheskogo-deystviyapreparata-deksalgin-deksketoprofena-trometamol-v-l/; Головачева АА, Головачева ВА. Комплексное лечение пациентов с хронической неспецифической болью в спине и коморбидными нарушениями: проспективное клиническое исследование. Неврология, нейропсихиатрия, психосоматика. 2024;16(6):45-52. doi:10.14412/2074-2711-2024-6-45-52; Moore RA, Barden J. Systematic review of dexketoprofen in acute and chronic pain. BMC Clin Pharmacol. 2008 Oct 31;8:11. doi:10.1186/1472-6904-8-11
-
13
Autoři: a další
Zdroj: Наука и здравоохранение. :108-112
Témata: пожилой возраст, arterial hypertension, renal failure, дәрілік өзара әрекеттесу, elderly age, почечная недостаточность, drug interactions, артериальная гипертензия, 3. Good health, лекарственные взаимодействия, pharmacotherapy, артериялық гипертензия, бүйрек жеткіліксіздігі, фармакотерапия, егде жас
-
14
Autoři: D. A. Sychev
Zdroj: Качественная клиническая практика, Vol 0, Iss 4, Pp 120-122 (2024)
Témata: RS1-441, клиническая фармакология, противомикробные средства, Pharmacy and materia medica, антибиотикотерапия, Medical technology, антибиотики, R855-855.5, фармакотерапия инфекционных заболеваний, 3. Good health
Přístupová URL adresa: https://doaj.org/article/93c2e3f1d3d248d18a3be0f55db8efb9
-
15
Zdroj: University Therapeutic Journal, Vol 6, Iss 2 (2024)
Témata: iSGLT2, парадокс ожирения, ожирение, Medicine, фармакотерапия, хроническая сердечная недостаточность, aGLP-1
Přístupová URL adresa: https://doaj.org/article/5a3ed23ec46f45b5834147a81df279fd
-
16
-
17
-
18
-
19
Autoři:
Zdroj: EMERGENCY MEDICINE; № 2.81 (2017); 140-144
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; № 2.81 (2017); 140-144
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; № 2.81 (2017); 140-144Témata: 03 medical and health sciences, 0302 clinical medicine, серцева недостатність, фармакотерапія, анестезіологічне забезпечення, сердечная недостаточность, фармакотерапия, анестезиологическое обеспечение, heart failure, pharmacotherapy, anesthetic management, 3. Good health
Popis souboru: application/pdf
-
20
Autoři:
Zdroj: Zdorovʹe Rebenka, Vol 10, Iss 2.61, Pp 70-74 (2015)
CHILD`S HEALTH; № 2.61 (2015); 70-74
Здоровье ребенка-Zdorovʹe rebenka; № 2.61 (2015); 70-74
Здоров'я дитини-Zdorovʹe rebenka; № 2.61 (2015); 70-74Témata: children, бронхиальная астма, церебральная гемодинамика, базисная фармакотерапия, дети, cerebral hemodynamics, bronchial asthma, basic pharmacotherapy, Pediatrics, бронхіальна астма, церебральна гемодинаміка, базисна фармакотерапія, діти, RJ1-570, 3. Good health
Popis souboru: application/pdf
Nájsť tento článok vo Web of Science